SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Canton Hathaway LLC

Canton Hathaway LLC decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,260 shares of the exchange traded fund’s stock after selling 1,685 shares during the period. Canton Hathaway LLC’s holdings in SPDR S&P Biotech ETF were worth $1,554,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in XBI. Golden State Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $29,000. Avior Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC grew its holdings in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $43,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $90.11 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The stock has a fifty day moving average of $91.26 and a two-hundred day moving average of $95.97. The company has a market capitalization of $6.87 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.